HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of idebenone for respiratory failure in a patient with Leigh syndrome: a long-term follow-up study.

Abstract
Respiratory failure can be the direct cause of death in patients with Leigh syndrome. Unfortunately, no effective treatment strategy is available. Here, we report successful treatment of a patient with Leigh syndrome using idebenone, a derivative of coenzyme Q-10. The patient's brainstem function, especially respiratory function, improved after idebenone treatment. Idebenone may be worth trying in patients with Leigh syndrome.
AuthorsKazuhiro Haginoya, Shigeaki Miyabayashi, Masahiro Kikuchi, Akira Kojima, Katsuya Yamamoto, Kiyoshi Omura, Mitsugu Uematsu, Naomi Hino-Fukuyo, Soichiro Tanaka, Shigeru Tsuchiya
JournalJournal of the neurological sciences (J Neurol Sci) Vol. 278 Issue 1-2 Pg. 112-4 (Mar 15 2009) ISSN: 0022-510X [Print] Netherlands
PMID19101701 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Ubiquinone
  • Lactic Acid
  • idebenone
Topics
  • Adolescent
  • Brain Stem (drug effects, physiopathology)
  • Evoked Potentials, Auditory, Brain Stem (drug effects)
  • Follow-Up Studies
  • Humans
  • Lactic Acid (cerebrospinal fluid)
  • Leigh Disease (complications)
  • Male
  • Polysomnography
  • Respiration (drug effects)
  • Respiratory Insufficiency (drug therapy, etiology)
  • Ubiquinone (analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: